Skip to main content
. 2016 Sep 1;10(9):QC04–QC07. doi: 10.7860/JCDR/2016/19009.8403

[Table/Fig-3]:

The maternal and foetal complications in the study and the control groups.

graphic file with name jcdr-10-QC04-g002.jpg
Variable No. of cases
in Anti TPO+
No. of cases
in Anti TPO-ve
Anemia 21 (52.5%) 7 (17.5%)
Preterm delivery 5 (12.5%) 1 (2.5%)
IUGR 6 (15%) 8 (20%)
Abruption 1 (2.5%) 0
Pre-edampsia 4 (10%) 2 (5%)
Gestational hypertension 8 (20%) 5 (12.5%)
PPH 1 (2.5%) 0